Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 346 of 6351
-
New hope for richter transformation: targeted drug combo heads to phase III
Disease control Not yet recruitingThis phase III trial compares the effect of adding pirtobrutinib to the usual treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) to R-CHOP alone for the treatment of Richter transformation, which is when chronic lymphocytic leukemia or sm…
Phase 3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Womb surgery for rare birth defect: will it save more babies?
Disease control By invitation onlyThe purpose of this research is to determine if babies who undergo a Fetoscopic Endoluminal Tracheal Occlusion (FETO) procedure survive more often and have less long-term complications than babies who have similarly severe Congenital Diaphragmatic Hernia (CDH) that have not had t…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New hope for NMOSD patients: drug aims to slash relapse rate
Disease control Not yet recruitingThe primary objective of this study is to confirm the efficacy, safety, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of ravulizumab in the treatment of Chinese adults with anti-aquaporin-4 (AQP4) antibody (Ab) + neuromyelitis optica spectrum disorder (NMOSD).
Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental drug cocktail takes on childhood brain cancers
Disease control Not yet recruitingThis study is researching an experimental drug called cemiplimab (called "study drug") and the combination of experimental drugs of fianlimab and cemiplimab (called "study drugs"). The study is focused on children and young adults with recurrent or progressive High-Grade Glioma (…
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for tough leukemia? drug duo targets TP53 mutations
Disease control Not yet recruitingThis is a single-center, open-label, phase I study with dose escalation and dose expansion testing the combination of ATRN-119 and decitabine in patients with TP53-mutated acute myeloid leukemia (AML) or higher-risk myelodysplastic syndrome (HR-MDS). The dose escalation phase wil…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug aims to cut heart risk for patients with high lp(a) after heart attack
Disease control Not yet recruitingCTQJ230A1US13 is a randomized, double-blind, placebo-controlled, multicenter phase IIIb study designed to evaluate the efficacy, safety, tolerability, and coronary plaque effects of early pelacarsen (TQJ230) initiation in participants with elevated Lp(a) and recent acute coronary…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Laser zaps brain tumor, then immunotherapy fights back: new hope for glioblastoma?
Disease control Not yet recruitingThis study will assess the therapeutic efficacy of the combination of Laser Interstitial Thermal Therapy (LiTT) with adjuvant cemiplimab compared to the therapeutic efficacy of the combination of LiTT with physician's choice of adjuvant chemotherapy in patients with recurrent gli…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Two-Drug cocktail aims to shrink Hard-to-Treat esophageal and stomach tumors
Disease control Not yet recruitingThis is a single-arm, multi-center phase II study to evaluate the efficacy and safety of sacituzumab tirumotecan (Sac-TMT/SKB264) combined with tagitanlimab (KL-A167) as 2nd line therapy for recurrent or metastatic esophageal squamous cell carcinoma (ESCC) or gastric/gastroesopha…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can a dissolving tablet improve recovery after a common stroke?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if Y-6 sublingual tablets work to improve functional outcomes in patients with acute perforating artery infarction. It will also learn about the safety of Y-6 sublingual tablets. The main questions it aims to answer are: Does Y-6 subl…
Phase 2/3 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a flexible dosing schedule improve esophageal cancer treatment?
Disease control Not yet recruitingThe purpose of this study is to evaluate the pharmacokinetic (PK) profile, safety, and efficacy of tislelizumab administered once every 2 weeks (Q2W) or once every 4 weeks (Q4W) in combination with chemotherapy as first-line treatment in Japanese participants with previously untr…
Phase 2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can an ancient herbal remedy soothe the aftermath of stone surgery?
Symptom relief Not yet recruitingThis study examines the efficacy and safety of Bushen Huoxue Simiao formula for tonifying the kidneys and promoting blood circulation in treating postoperative complications of upper urinary tract stones, thereby providing evidence-based medical evidence and treatment strategies …
Phase 4 • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can an oral pill boost muscle strength in pompe disease?
Disease control Not yet recruitingThe primary purpose of this study is to evaluate the long-term safety and tolerability profile of S-606001 in participants with LOPD. Participants who completed other S-606001 studies (for example, NCT07123155), including participants in a S-606001 study whose allocated arm was …
Phase 2 • Sponsor: Shionogi • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a new pill quiet the inflammation of rheumatoid arthritis?
Disease control Not yet recruitingThis study is designed to assess the safety, pharmacokinetics (PK), and biomarker effects of PTC844 compared to placebo in participants with active rheumatoid arthritis (RA).
Phase 2 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
AI-Powered brain games and exercise may revitalize stroke survivors
Disease control Not yet recruitingCEEEC-II is a 12-week, community-based, prospective extension study conducted in 32 community health service stations in Kunshan, China. It will invite older stroke survivors with hypertension and/or type 2 diabetes who participated in the preceding CEEEC Phase I trial (NCT069755…
Sponsor: Duke Kunshan University • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can lower pressure make complex surgery safer and speed recovery?
Disease control Not yet recruitingWhen performing minimally invasive (MIS) hepato-pancreato-biliary (HPB) surgery, an air seal is used for optimal space and visibility of the surgical field. This is typically done at a pressure of 10-15 mmHg, but can also come with risks of serious complications. HBP surgeries ar…
Sponsor: Juan Glinka • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a 100,000-Patient global audit reveal how to make surgery safer?
Knowledge-focused Not yet recruitingThis study aims to assess and improve the global outcomes following surgery. Every year approximately 313 million operations are performed, with 50 million people experiencing a complication and unfortunately 3.5 million people will die following these operations. This study will…
Sponsor: University of Birmingham • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Olive oil and fish: a recipe for a healthier liver?
Prevention Recruiting nowThis prospective randomized dietary intervention study investigates the effects of two dietary approaches on liver health in young adults over a 12-week period. Participants will be randomly assigned to either a Mediterranean diet intervention or a healthy diet based on general d…
Sponsor: Hochschule Campus Wien (University of Applied Sciences Campus Vienna) • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
Can a hormone coil shield the womb from estrogen's risks?
Knowledge-focused Not yet recruitingThis is an observational study in which researchers will use claims data already collected from women in the United States who received their usual care. The study will look at women aged 40 years and older who have a uterus and started estrogen therapy. Estrogen therapy is ofte…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Could daily swallowing exercises ease a harsh side effect of cancer treatment?
Symptom relief Not yet recruitingThis study aims to evaluate the effect of a structured swallowing rehabilitation program on swallowing function, trismus severity, and pain among patients with head and neck tumors, using a randomized controlled trial design. Eighty patients will be randomly allocated into two eq…
Sponsor: Delta University for Science and Technology • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Magnetic pulses to the brain may help cancer patients sleep better
Symptom relief Not yet recruitingThis randomized, double-blind, sham-controlled trial will evaluate whether low-frequency repetitive transcranial magnetic stimulation (rTMS) can improve in-hospital sleep quality in adults with advanced non-small cell lung cancer (NSCLC) and clinically significant in-hospital sle…
Phase 2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC